Diatech Diabetes is a medical technology company led by people with diabetes whose mission is to improve the health outcomes of others with diabetes through personalized technology. Two million patients utilize insulin pumps, yet 97% of pump users experience insulin infusion failures that can cause increased costs and dangerous blood glucose levels. Diatech Diabetes solution is Smartfusion™, an infusion monitoring software that detects insulin infusion failure and provides insights on how infusion performance affects diabetes management. Smartfusion helps reduce the impact of insulin infusion failure for people living with diabetes.
John Wilcox is the founder and CEO of Diatech Diabetes. John’s mission is to build technology that improves the lives of people living with diabetes. John was diagnosed with diabetes on his 9th birthday, making his mission deeply personal. During his undergraduate work, he co-founded Diatech Diabetes with Luis E. Blanco, whose family is also affected by diabetes. Diatech Diabetes focuses on developing software products to help with glucose management for the more than 422 million people with diabetes worldwide. John has a MS degree in diabetes education and management at Columbia University. He is incredibly passionate about diabetes advocacy, proving so as he is a five-time marathon charity runner for diabetes research.